Dallan Murray

Chief Customer Officer, Sarepta Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Mar 10, 2025Granted 8,276 shares of Sarepta Therapeutics²
Mar 10, 2025Shares withheld for tax 2,737 shares at $100.13 of Sarepta Therapeutics²
Mar 10, 2025Shares withheld for tax 996 shares at $100.13 of Sarepta Therapeutics²
Mar 7, 2025Shares withheld for tax 8,613 shares at $103.70 of Sarepta Therapeutics³
Mar 7, 2025Shares withheld for tax 549 shares at $103.70 of Sarepta Therapeutics³
Mar 7, 2025Exercised options 5,500 shares of Sarepta Therapeutics²
Mar 6, 2025Exercised options 17,500 shares of Sarepta Therapeutics³
Mar 4, 2025Shares withheld for tax 1,685 shares at $101.34 of Sarepta Therapeutics⁴
Mar 3, 2025Shares withheld for tax 711 shares at $103.77 of Sarepta Therapeutics⁵
Jun 24, 2024Shares withheld for tax 2,352 shares at $164.64 of Sarepta Therapeutics⁶
Jun 21, 2024Exercised options 6,250 shares of Sarepta Therapeutics⁶
May 2, 2024Sold 3,635 shares at $140.00 of Sarepta Therapeutics⁷

The numbers on this page point here. Each one links to the record it came from.